1. Home
  2. JWEL vs INDP Comparison

JWEL vs INDP Comparison

Compare JWEL & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JWEL
  • INDP
  • Stock Information
  • Founded
  • JWEL 2012
  • INDP 2000
  • Country
  • JWEL China
  • INDP United States
  • Employees
  • JWEL N/A
  • INDP N/A
  • Industry
  • JWEL Other Consumer Services
  • INDP Biotechnology: Pharmaceutical Preparations
  • Sector
  • JWEL Consumer Discretionary
  • INDP Health Care
  • Exchange
  • JWEL Nasdaq
  • INDP Nasdaq
  • Market Cap
  • JWEL 5.2M
  • INDP 6.0M
  • IPO Year
  • JWEL 2021
  • INDP N/A
  • Fundamental
  • Price
  • JWEL $2.20
  • INDP $9.92
  • Analyst Decision
  • JWEL
  • INDP Strong Buy
  • Analyst Count
  • JWEL 0
  • INDP 2
  • Target Price
  • JWEL N/A
  • INDP $238.00
  • AVG Volume (30 Days)
  • JWEL 23.8K
  • INDP 26.5K
  • Earning Date
  • JWEL 08-05-2025
  • INDP 08-11-2025
  • Dividend Yield
  • JWEL N/A
  • INDP N/A
  • EPS Growth
  • JWEL N/A
  • INDP N/A
  • EPS
  • JWEL N/A
  • INDP N/A
  • Revenue
  • JWEL $132,981,531.00
  • INDP N/A
  • Revenue This Year
  • JWEL N/A
  • INDP N/A
  • Revenue Next Year
  • JWEL N/A
  • INDP N/A
  • P/E Ratio
  • JWEL N/A
  • INDP N/A
  • Revenue Growth
  • JWEL N/A
  • INDP N/A
  • 52 Week Low
  • JWEL $1.18
  • INDP $7.56
  • 52 Week High
  • JWEL $3.71
  • INDP $59.36
  • Technical
  • Relative Strength Index (RSI)
  • JWEL 49.79
  • INDP 42.75
  • Support Level
  • JWEL $2.02
  • INDP $11.20
  • Resistance Level
  • JWEL $2.50
  • INDP $10.91
  • Average True Range (ATR)
  • JWEL 0.23
  • INDP 0.86
  • MACD
  • JWEL -0.03
  • INDP -0.25
  • Stochastic Oscillator
  • JWEL 29.03
  • INDP 7.94

About JWEL Jowell Global Ltd.

Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing. Geographically, it generates all of its revenue from the PRC.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: